Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Ketoconazole before Surgery in Treating Patients with Recurrent Glioma or Breast Cancer Metastatic to the Brain

Trial Status: administratively complete

There is a specific protein called tGLI1 that is often found in brain tumors. It has been linked to more aggressive tumors. Ketoconazole is an antifungal drug that has been shown in animals and cells to reduce tGLI1 and block its functions. This early phase I trial studies the side effects and how well ketoconazole works before surgery in treating patients with glioma that has come back (recurrent) or breast cancer that has spread (metastatic) to the brain. This study may teach scientists how to treat or prevent these tumor types in the future.